Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
Sign Up to like & getrecommendations! Published in 2020 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2020.2762
Abstract: Importance Concerns exist that use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of developing type 2 diabetes (T2D) in adults, but evidence in children and adolescents is limited. In the absence of a… read more here.
Keywords: risk; treatment; publicly insured; ssri treatment ... See more keywords
The Impact of Prolonged, Selective, Serotonin Reuptake Inhibitor Treatment on Serum Lipid and Glucose Levels in Children and Adolescents: A Preliminary Prospective Study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of child and adolescent psychopharmacology"
DOI: 10.1089/cap.2018.0055
Abstract: OBJECTIVES Treatment with selective serotonin reuptake inhibitors (SSRIs) is common and is considered safe and effective in the treatment of anxiety and depressive disorders in pediatric populations. SSRI administration, however, is associated with adverse metabolic… read more here.
Keywords: selective serotonin; serotonin reuptake; treatment; serum ... See more keywords
Intensity-Dependence of Auditory Evoked Potentials (IDAP) as a Neurophysiological Parameter to Predict Anti-Aggressive Responsiveness to SSRI Treatment
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.716338
Abstract: The rationale for selective serotonin reuptake inhibitor (SSRI) treatment in patients with aggressive behavior comes from several studies aimed at comprehending the neurobiological basis of anger and aggression and, in particular, at investigating the involvement… read more here.
Keywords: aggressive behavior; aggression; ssri treatment; intensity dependence ... See more keywords
Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.1012650
Abstract: Background Using other central nervous system (CNS) medications in combination with selective serotonin reuptake inhibitor (SSRI) treatment is common. Despite this, there is limited evidence on the impact on suicidal behavior of combining specific medications.… read more here.
Keywords: ssri treatment; suicidal behavior; risk; treatment ... See more keywords